Frontiers

Altered Metabolic Traits in Gastrointestinal Tract Cancers, volume II

Given the success of the <a href=" edition of Altered Metabolic Traits in Gastrointestinal Tract Cancers, we are pleased to announce the Volume II.<br/><br/>The field of gastrointestinal (GI) tract ...
ascopubs.org

Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program

Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study A total of 11 gastrointestinal cancers were ...
The American Journal of Managed Care

Immunotherapy Considerations for Upper GI and Esophageal Cancer Treatment Pathways

Key opinion leaders emphasize the significant role of immunotherapy for patients being treated for gastroesophageal cancer. James M. Cleary, MD, PhD: Increasingly, hospitals—including mine—have ...
Frontiers

Exploring key pathways in the progression of gastrointestinal diseases based on metabolic reprogramming and developing drugs targeting metabolism

Digestive tract tumors are malignant diseases characterized by high aggressiveness, heterogeneity and metabolic abnormalities. Heterogeneity and drug resistance among tumors pose a serious challenge ...